Home / Europe / United Kingdom
a view from the london skyline from the millenium bridge

United Kingdom

Europe

At CMS, we always strive to put our clients at the centre of what we do. We advise clients on matters that range from global multi-billion dollar deals to ground-breaking commercial agreements.

Headquartered in the centre of the City of London with a 250 year heritage, and with offices in Aberdeen, Bristol, Edinburgh, Glasgow, Liverpool, Manchester, Reading and Sheffield, CMS UK works across international borders and all industry sectors and commercial areas of law.

With more than 70 offices in more than 40 countries and 5,000+ lawyers worldwide, CMS globally has the depth of resource to ensure end-to-end delivery on both international and national projects.

Part of our commitment to provide solutions tailored to our clients’ needs is our industry sector focus. Our priority sectors are financial services, technology, media and communications, energy and lifesciences. We are also a full service law firm working across banking and finance, commercial, competition & EU, consumer products, corporate, dispute resolution, employment & pensions, hotels & leisure, infrastructure & project finance, insurance & funds, intellectual property, private equity, real estate & construction and tax.

Business-focused advice is central to the services we offer, so we are proud to partner with the top management business school in Switzerland, IMD.

Our London headquarters at Cannon Place is designed around our clients and using the latest technology innovations, they epitomise a modern law firm. When you visit CMS in London, you are welcome to use our Tech Hub to work and catch up on the latest news, and to use our state-of-the-art meeting spaces.

If you do business in the UK, please reach out via our online contact form or give us a call.

Read more Read less
  • experts for
  • Jurisdictions

Feed

23/03/2023
A glob­al move to­wards ban­ning em­ploy­ment con­tract non-com­pete clauses?...
What does the fu­ture hold for busi­nesses look­ing to re­tain law­fully their mar­ket po­s­i­tions and pre­vent un­fair com­pet­i­tion from ex-em­ploy­ees, share­hold­ers and oth­er stake­hold­ers? Re­cent de­vel­op­ments in...
23/03/2023
European Pat­ent Of­fice (EPO) dig­ging its heals in over the need for de­scrip­tion...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
27/04/2023
CMS Shef­field Con­struc­tion Fo­cus
We are very pleased to wel­come you to the latest edi­tion of our Con­struc­tion Fo­cus break­fast sem­in­ar series, tak­ing place at our Shef­field of­fices on 27 April 2023. This event is the second in­stal­ment...
22/03/2023
ESG in­vest­ing - key con­sid­er­a­tions
En­vir­on­ment­al, So­cial, and Gov­ernance (“ESG”) in­vest­ing is the con­sid­er­a­tion of ESG factors along­side fin­an­cial factors in the in­vest­ment de­cision-mak­ing pro­cess. By in­teg­rat­ing ESG con­sid­er­a­tions in­to fin­an­cial de­cisions, in­vestors can align in­vest­ments with their val­ues, pro­mote sus­tain­able eco­nom­ic growth, and mit­ig­ate risk.
22/03/2023
European Pat­ent Of­fice (EPO) level of dis­clos­ure re­quired for an­ti­bod­ies...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
22/03/2023
CMS European M&A Study 2023
The CMS Cor­por­ate/M&A Group is pleased to launch the 15th edi­tion of the European M&A Study
22/03/2023
CMS ad­vises Com­cast on new stream­ing part­ner­ship in Africa
In­ter­na­tion­al law firm CMS ad­vised NB­CUni­ver­sal and Sky (both owned by Com­cast) on their new part­ner­ship with Afric­an me­dia com­pany Mul­tiChoice Group for the Show­max stream­ing ser­vice.  CMS ad­vised on...
21/03/2023
Is a pa­tient in a clin­ic­al tri­al con­sidered to be a mem­ber of the pub­lic...
In T 0670/20, the ques­tion was wheth­er the in­tern­al struc­ture of medi­cin­al tab­lets had been made avail­able to the pub­lic by pa­tients tak­ing part in clin­ic­al tri­als in­volving ad­min­is­tra­tion of the tab­lets...
21/03/2023
CMS Ex­pert Guide to di­git­al health apps and telemedi­cine
Fu­ture fa­cing Di­git­isa­tion is ad­van­cing stead­ily. Its pi­on­eer­ing in­nov­a­tions chal­lenge all parties in­volved. One of the most im­port­ant as­pects in this area is the huge po­ten­tial that lies in the di­git­isa­tion...
Comparable
21/03/2023
CMS Ex­pert Guide to whis­tleblower pro­tec­tion & re­port­ing chan­nels
In Oc­to­ber 2019, in the wake of a num­ber of whis­tleblower rev­el­a­tions (es­pe­cially the in­dus­tri­al-scale tax avoid­ance schemes re­vealed in the LuxLeaks scan­dal), the European Uni­on ad­op­ted the Whis­tleblower...
Comparable
20/03/2023
Men­tal health in a cost-of-liv­ing crisis
The Men­tal Health Found­a­tion re­cently pub­lished a re­port say­ing that they ex­pect the ef­fects of the cost-of-liv­ing crisis on pub­lic men­tal health to be on a scale sim­il­ar to the COV­ID-19 pan­dem­ic. Over...
20/03/2023
The Su­preme Court has held that Ukraine can de­fend USD$3 bil­lion con­trac­tu­al...
Sum­mary­In a highly an­ti­cip­ated judg­ment, the UK Su­preme Court has un­an­im­ously dis­missed the sum­mary judg­ment ap­plic­a­tion made by the Law Deben­ture Trust Cor­por­a­tion plc (the “Trust­ee”), act­ing on...